is mounjaro a glp 1 medication Compare GLP-1 Options | Ozempic v | WeightWatchers GLP-1 Weight Loss Medications Compared:

Common GLP-1 medications prescribed in 2025 include: Semaglutide (Wegovy, Ozempic) Tirzepatide (Mounjaro) Liraglutide (Saxenda) Peer-reviewed clinical trials published in journals such as The New England Journal of Medicine and JAMA document average body weight reductions of approximately 1022% over 612 months when GLP-1 medications are combined with lifestyle support and ongoing physician oversight

Conversely, evening or bedtime administration may benefit some patients who find that sleeping through the initial hours after injection helps them avoid or minimize awareness of nausea

The preclinical research with liraglutide showed better stroke outcomes alongside reduced stroke severity and improved functional results because of its ability to increase vascular endothelial growth factor (VEGF) expression [13]

B., Ding, P., Riddell, C

Research in animal models and population studies suggests GLP-1 receptor agonists may reduce dementia risk and improve cognitive function, but clinical trials are still ongoing

The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin is released only when blood glucose levels are elevated, reducing hypoglycemia risk when used as monotherapy (though risk increases when combined with insulin or sulfonylureas)